| ¿µ¹® | cardiovascular system | ÇÑ±Û | ½ÉÀåÇ÷°ü°è |
|---|---|---|---|
| ¼³¸í | ½ÅüÀÇ Ç÷¾×¼øÈ¯À» ´ã´çÇÏ´Â ±â°ü. Áï ½ÉÀå°ú Ç÷°üÀ» ÅëÄªÇØ¼ À̸£´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | autonomic nervous system | ÇÑ±Û | ÀÚÀ²½Å°æ°è |
|---|---|---|---|
| ¼³¸í | »ç¶÷ÀÇ ÀÇÁö¿Í °ü°è¾øÀÌ, ħÀ» È긮°Å³ª ¼Òȿ µî°ú °°Àº ½º½º·Î Á¶Á¤ÀÌ µÇ¾î ¿òÁ÷ÀÌ´Â ½Å°æ°èÀÌ¸ç ¿©±â¿¡´Â ´ÙÀ½°ú °°Àº µÎ °¡Áö°¡ ÀÖ´Ù. 1.±³°¨½Å°æ°è(sympathetic nervous system)-»ç¶÷ÀÌ À§Çè»óÅ¿¡ À̸£·¶À» °æ¿ì¿¡ ÈïºÐÀÌ µÇ´Â ÀÚÀ²½Å°æ°è. Áï ½É¹Ú¼öÀÇ Áõ°¡, ¼Òȱ⠿ÀÇ °¨¼Ò µîÀÇ ÀÏÀÌ À̰÷À» ÅëÇØ¼ ÀϾÙ. ±³°¨½Å°æÀÌ ÈïºÐµÇ¸é ±³°¨½Å°æÀÇ ¸»´Ü¿¡¼ epinephrine, norepinephrine µîÀÇ ¹°ÁúÀÌ ºÐºñµÇ°í À̰͵鿡 ÀÇÇØ¼ ¸»ÃÊÀå±â°¡ º¯È¸¦ ÀÏÀ¸Å²´Ù. ÇÏÁö¸¸ Àå±â¿¡ µû¶ó¼ epinephrineÀ̳ª norepinephrineÀÇ ¼ö¿ëü¸¦ °¡Áö°í ÀÖ¾î¼ ¿©·¯ °¡Áö ´Ù¸¥ Àå±âÀÇ ¹ÝÀÀÀ» º¼ ¼ö°¡ ÀÖ´Ù. ¼ö¿ëü´Â ´ÙÀ½°ú °°´Ù. -¾ËÆÄ¼ö¿ëü(alpha-receptor): ¸»ÃÊÇ÷°üÀÇ ¼öÃà, ±â°üÁöÀÇ ¼öÃà, µ¿°øÀÇ ±ÙÀ°ÀÇ ¼öÃà -º£Å¸1¼ö¿ëü(beta 1-receptor): ½ÉÀå¿¡ Á¸ÀçÇÏ´Â ¼ö¿ëü, ½ÉÀåÀ» »¡¸® ¶Ù°ÔÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. -º£Å¸2¼ö¿ëü(beta 2-receptor): Ç÷°üÀÇ ÀÌ¿Ï, ±â°üÁöÀÇ ÀÌ¿Ï, Áï °¢ Àå±âµéÀº ±× Àå±â°¡ °¡Áö°í ÀÖ´Â ±³°¨½Å°æÀÇ ¼ö¿ëü¿¡ µû¶ó ±³°¨½Å°æÀÇ ÈïºÐ(±³°¨½Å°æ ¸»´Ü¿¡¼ÀÇ epinephrineÀÇ ºÐºñ)¿¡ ´ëÇÑ ¹ÝÀÀÀÌ ´Þ¶óÁø´Ù(¿¹-±³°¨½Å°æÀÌ ÈïºÐ½Ã¿¡ beta 1-¼ö¿ëü¸¦ °¡Áö°í ÀÖ´Â ½ÉÀåÀº »¡¸® ¶Ù°Ô µÈ´Ù. ±³°¨½Å°æ ÈïºÐ½Ã¿¡ µ¿°øÀÇ ±ÙÀ°ÀÌ ¼öÃàÇØ¼ µ¿°øÀÇ Å©±â°¡ Ä¿Áø´Ù) 2.ºÎ±³°¨½Å°æ°è(parasympathetic nervous system)-±³°¨½Å°æ°ú ¹Ý´ë·Î ÀÛ¿ëÇÑ´Ù. Áï »ç¶÷ÀÌ Á¹¸®°Å³ª ½¯ °æ¿ì¿¡ ÈïºÐÇÑ´Ù. ºÎ±³°¨½Å°æÀÌ ÈïºÐÇÒ ¶§¿¡´Â ½Å°æÀÇ ¸»´Ü¿¡¼ ¾Æ¼¼Ä¥Äݸ°ÀÇ ºÐºñ°¡ ÀϾ°í À̰ÍÀ¸·Î ÀÎÇØ¼ °¢ Àå±âÀÇ º¯È°¡ ÀϾÙ. |
||
| ¿µ¹® | TNM staging system | ÇÑ±Û | Á¾¾çº´±âºÐ·ù°èÅë |
|---|---|---|---|
| ¼³¸í | Á¾¾çÀÇ º´±â(stage)¸¦ °áÁ¤ÇÏ´Â ÇÑ ¹æ¹ý. T´Â Tumor(Á¾¾ç)¸¦ ¶æÇÏ¸ç ¿ø¹ßº´ÅÍÀÇ Å©±â, ÁÖÀ§Á¶Á÷À¸·ÎÀÇ Ä§À±Á¤µµ µî¿¡ µû¶ó T1, T2, T3, T4(¼ýÀÚ°¡ ³ôÀ» ¼ö·Ï ÁÖÀ§·Î ħÀ±ÀÌ ¸¹´Ù) µîÀ¸·Î ³ª´«´Ù. NÀº Node(¸²ÇÁÀý)¸¦ ¶æÇϸç ħ¹üµÈ ¸²ÇÁÀýÀÇ °¹¼ö, Å©±â, À§Ä¡ µî¿¡ µû¶ó N1, N2, N3 µîÀ¸·Î ³ª´«´Ù. MÀº Metastasis(ÀüÀÌ)¸¦ ¶æÇÏ¸ç ¿ø°ÝÀüÀÌÀÇ À¯¹«¿¡ µû¶ó M0, M1 µîÀ¸·Î ³ª´«´Ù. ÀÌ»óÀÇ ¹æ¹ýÀ¸·Î T, N, MÀÌ °áÁ¤µÇ¸é À̵éÀ» Á¶ÇÕÇÏ¿© ÃÖÁ¾ÀûÀÎ º´±â¸¦ °áÁ¤ÇÑ´Ù. ÀÌ·¸°Ô °áÁ¤µÈ º´±â´Â Ä¡·á ¹æÄ§ °áÁ¤°ú ¿¹ÈÄ ÆÇ´Ü¿¡ ¸Å¿ì Áß¿äÇÏ´Ù. |
||
| ¿µ¹® | central nervous system(CNS) | ÇÑ±Û | ÁßÃ߽Űæ°è |
|---|---|---|---|
| ¼³¸í | ½Å°æ°è´Â ÁßÃ߽Űæ°è¿Í ¸»ÃʽŰæ°è·Î ºÐ·ùÇÒ ¼ö°¡ ÀÖ´Ù. ÁßÃ߽Űæ°è¶õ ³ú¿Í ô¼ö·Î ±¸¼ºµÇ¾î ÀÖ´Â ½Å°æ°è¸¦ À̸£´Â ¸»ÀÌ´Ù. ¸»ÃʽŰæ°è¶õ ÀÌ ÀÌ¿ÜÀÇ ¸ðµç ½Å°æ°è¸¦ À̸£´Â ¸»ÀÌ´Ù. |
||
| LFA | left femoral artery; left frontal craniotomy; left fronto-anterior [fetal position]; leukocyte funct... |
|---|---|
| LFT | latex fixation test; latex flocculation test; left fronto-transverse [fetal position]; liver functio... |
| SFI | Sexual Function Index; Social Function Index |
| TORCH | toxoplasmosis, other [congenital syphilis and viruses], rubella, cytomegalovirus, and herpes simplex... |
| ABCDES | abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi... |
| intervention studies | Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population. (12 Dec 1998) |
|---|---|
| intracardiac electrophysiology studies | <cardiology, investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart. This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined. This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation. (27 Sep 1997) |
| organizational case studies | Descriptions and evaluations of specific health care organizations. (12 Dec 1998) |
| electrophysiological studies | <investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart. This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined. This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation. Acronym: EPS (14 Mar 2000) |
| epidemiologic studies | Studies designed to examine associations, commonly, hypothesised causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are case-control studies, cohort studies, and cross-sectional studies. (12 Dec 1998) |
| evaluation studies | Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, clinical trials, drug evaluation, and drug screening are available. (12 Dec 1998) |
| twin studies | Methods of detecting genetic aetiology in human traits. The basic premise of twin studies is that monozygotic twins, being formed by the division of a single fertilised ovum, carry identical genes, while dizygotic twins, being formed by the fertilization of two ova by two different spermatozoa, are genetically no more similar than two siblings born after separate pregnancies. (12 Dec 1998) |
| feasibility studies | Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. (12 Dec 1998) |
| follow-up studies | Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. (12 Dec 1998) |
| longitudinal studies | Studies in which variables relating to an individual or group of individuals are assessed over a period of time. (12 Dec 1998) |
| acquired platelet function defect | <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines). Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation. (29 Dec 1997) |
| allomeric function | The combined function of the several segments of the spinal cord and medulla, communicating with each other by means of the white matter. (05 Mar 2000) |
| aperture function | <microscopy> In a diffraction-limited optical system, the function that determines the relationship between the image and each point in the object. Modifying the aperture function changes the image according to the modified Fourier-filtering (or optical filtration) property of the aperture. (05 Aug 1998) |
| arousal function | The ability of a sensory event to arouse the cortex to vigilance or readiness. (05 Mar 2000) |
| atrial function | The haemodynamic and electrophysiological action of the atria. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|